Conjugated Linoleic Acid (CLA) for Weight Loss

Verdict: CLA does not meaningfully aid weight loss

Conjugated linoleic acid (CLA) produces, at best, a tiny and clinically meaningless reduction in body weight and fat, and major regulators and physician groups do not endorse it for weight loss. It is not a worthwhile weight-loss supplement.

D 🔴 D Counter-Evidence Disputed

🔬Why this grade7-layer evidence engine

Three meta-analyses agree on the same disappointing picture: a statistically detectable but trivially small effect. Whigham 2007 (PMID 17490954) pooled 18 trials and found fat loss of roughly 0.09 kg per week. Onakpoya 2012 (PMID 21990002) reported weight down only 0.70 kg and fat down 1.33 kg after six-plus months. Namazi 2018 (PMID 29672124) found weight down 0.52 kg, fat down 0.61 kg, and BMI down 0.23. The later authors explicitly called these effects not clinically relevant or considerable.

Regulators and clinicians line up against a weight-loss role. The EU's EFSA rejected CLA's body-fat claims, reasoning that fat loss paired with rising lipid-peroxidation and inflammation markers is not a beneficial effect. The US FDA recognizes CLA only as safe in foods and authorizes no weight-loss claim, while the WHO now treats CLA as a trans fat to keep below 1% of calories. The AAFP states plainly that no human data support CLA in weight-loss products.

That combination earns the D counter-evidence, disputed grade. The single positive signal is a small BMI dip, but that isolated surrogate does not equal real fat loss, and safety caveats, including the t10,c12 isomer's link to insulin resistance and a few liver-toxicity case reports, reinforce a do-not-recommend conclusion. Diet, exercise, and structured behavioral programs remain the evidence-based options.

⚖️

Scoring transparency

All scores computed by a 7-layer evidence engine — fully auditable
Raw score 0.52
D
C
B
A
S
← counter-evidence / ineffectiveeffective / strong evidence →
Final grade
D · Disputed
Confidence
64%
Broadly consistent
Evidence level
E2
Multiple high-quality MAs (≥2 independent, consistent)

How strongly each layer supports this effect

lower = less supportive
L11 AI re-checkIndependent read
0.30
L5 Clinical bodiesAuthoritative stance
0.31
L2 PubMedPrimary literature
0.60
L3 MechanismPlausibility
0.65
L1 ExamineGlobal benchmark
0.70
Against Mixed Supports
View the full decision path (audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.52
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (2 篇 > 0 negative)
  4. tier_strict_requirement_check — | C→D 因 scope.conflation_risk=true 且 L11 獨評較低 (B7-2 tier cap)
  5. detect_disputes — 偵測到 1 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

📄PubMed studies (3)L2 · primary research & systematic reviews

Efficacy of conjugated linoleic acid for reducing fat mass: a meta-analysis in humans
PMID: 17490954 2007 統合分析
Finding: Pooling 18 RCTs, CLA produced a small but statistically significant fat loss of 0.09 +/- 0.08 kg/week vs placebo (p<0.001); effect was approximately linear through 6 months and approached asymptote by 2 years, with dose-response of -0.024 kg fat/g CLA/week (p=0.03).
Effect size: [object Object]
View on PubMed
The efficacy of long-term conjugated linoleic acid (CLA) supplementation on body composition in overweight and obese individuals: a systematic review and meta-analysis of randomized clinical trials
PMID: 21990002 2012 統合分析
Finding: Long-term (>=6 mo) CLA significantly reduced body weight (MD -0.70 kg, 95% CI -1.09 to -0.32) and fat mass (MD -1.33 kg, 95% CI -1.79 to -0.86) vs placebo across 7 RCTs, but the authors explicitly concluded that the evidence does not convincingly show CLA generates any clinically relevant effects on body composition long-term because the magnitudes are too small.
🟢 High quality Effect size: [object Object]
View on PubMed
The effects of supplementation with conjugated linoleic acid on anthropometric indices and body composition in overweight and obese subjects: A systematic review and meta-analysis
PMID: 29672124 2019 統合分析
Finding: Across 13 RCTs in overweight/obese adults, CLA significantly reduced body weight (WMD -0.52 kg, 95% CI -0.83 to -0.21, p=0.01), BMI (WMD -0.23 kg/m^2, 95% CI -0.39 to -0.06, p=0.0001) and fat mass (WMD -0.61 kg, 95% CI -0.98 to -0.24, p=0.01), and slightly increased lean body mass (WMD +0.19 kg, p=0.0001); waist circumference unchanged (p=0.93). Authors concluded the efficacy is statistically significant but "not clinically considerable".
🟢 High quality Effect size: [object Object]
View on PubMed

🏛️Regulatory & authoritative positionsL4/L5 · FDA / EMA / NIH ODS / Cochrane / Mayo …

L4a US FDA
Supportive
FDA has no questions. The notice concerns conjugated linoleic acid isomers intended for use as an ingredient in certain specified foods within the general categories of soy milk, meal replacement beverages and bars, milk products and fruit juices at levels up to 3 grams per serving. source↗
L4b EU EFSA
Against
The Panel considers that the information provided does not establish that a reduction in body fat mass, when accompanied by an increase in markers of lipid peroxidation and inflammation, is a beneficial physiological effect for the target population. source↗
L4d TW TFDA / 衛福部
Neutral
已公告的健康食品規格標準(雙軌制第二軌)目前僅有「魚油」與「紅麴」兩項;其餘成分(包含共軛亞麻油酸 CLA)若欲取得「健康食品(小綠人)」標章,須循第一軌個案審查,提交安全性、功效性、安定性試驗報告,由衛生福利部審查取得「衛部健食字」許可證後方得宣稱13項法定保健功效之一。 source↗
L4e WHO
Cautious
For the purposes of these recommendations, TFA includes all fatty acids with a double bond in the trans configuration, regardless of whether the TFA come from ruminant sources or are produced industrially. [footnote 6:] This definition includes conjugated linoleic acid. source↗
L5a NIH Office of Dietary Supplements
Cautious
L5e Specialty Society (condition-mapped)
Against
Currently, no human data support the efficacy of CLA in weight-loss products. source↗
PMID 100% verifiedevery citation checked via NCBI Entrez
🔬3 PubMed studiesindependently re-checked by multiple sub-agents
engine_version: v1.0 claim_id: CLM-COND-weight-loss-INT-conjugated-linoleic-acid-001 繁體中文版 →